The Role of Lazertinib in Patients With EGFR-Variant Non-Small Cell Lung Cancer

被引：0
|
作者：
Cheng, Haiying [1 ]
机构：
[1] Montefiore Med Ctr, Albert Einstein Coll Med, Montefiore Einstein Comprehens Canc Ctr, Dept Med Oncol, 1695 Eastchester Rd,2nd Floor, New York, NY 10461 USA
来源：
JAMA ONCOLOGY | 2024年 / 10卷 / 10期
关键词：
D O I：
10.1001/jamaoncol.2024.2607
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1352 / 1353
页数：2
相关论文
共 50 条
  • [41] Neurological Death is Common in Patients With EGFR Mutant Non-Small Cell Lung Cancer
    Ramotar, M.
    Barnes, S.
    Doherty, M.
    Shultz, D.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S695 - S695
  • [42] CLINICOPATHOLOGICAL FEATURES IN NON-SMALL CELL LUNG CANCER PATIENTS WITH EGFR AND KRAS MUTATIONS
    Nishii, Teppei
    Yokose, Tomoyuki
    Miyagi, Yohei
    Ito, Hiroyuki
    Watanabe, Masato
    Imamura, Naoko
    Isaka, Tetsuya
    Imai, Kentaro
    Karino, Fumi
    Murakami, Shuji
    Kondo, Tetsuro
    Saito, Haruhiro
    Oshita, Fumihiro
    Yamada, Kouzo
    Nakayama, Haruhiko
    Masuda, Munetaka
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S965 - S965
  • [43] Role of Circulating Tumor DNA Profiling in Patients with Non-Small Cell Lung Cancer Treated with EGFR Inhibitor
    Ku, Bo Mi
    Kim, Yeon Jeong
    Park, Donghyun
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    Sun, Jong-Mu
    ONCOLOGY, 2022, 100 (04) : 228 - 237
  • [44] Polymorphisms in intron 1 of the EGFR gene in non-small cell lung cancer patients
    Shitara, Masayuki
    Sasaki, Hidefumi
    Yokota, Keisuke
    Okuda, Katsuhiro
    Hikosaka, Yu
    Moriyama, Satoru
    Yano, Motoki
    Kawaguchi, Tomoya
    Kubo, Akihito
    Takada, Minoru
    Kitahara, Naoto
    Okumura, Meinoshin
    Matsumura, Akihide
    Iuchi, Keiji
    Fujii, Yoshitaka
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 4 (05) : 785 - 789
  • [45] AFATINIB FOR THE TREATMENT OF PATIENTS WITH EGFR-POSITIVE NON-SMALL CELL LUNG CANCER
    Bowles, D. W.
    Weickhardt, A.
    Jimeno, A.
    DRUGS OF TODAY, 2013, 49 (09) : 523 - 535
  • [46] MUTATION ANALYSIS OF THE EGFR GENE IN PATIENTS WITH NON-SMALL CELL LUNG CANCER IN XINJIANG
    Shi, Yi
    Pang, Xue-Lian
    Ma, Zhi-Ping
    Cui, Wen-Li
    Zhang, Wei
    Ma, Yu-Qing
    ACTA MEDICA MEDITERRANEA, 2021, 37 (06): : 3363 - 3368
  • [47] EGFR Tyrosine Kinase Inhibitors in Patients with Non-Small Cell Lung Cancer and the Role of Diabetes Mellitus and Metformin
    Cipriano, E.
    Magalhaes, H.
    Estevinho, F.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S622 - S622
  • [48] Efficacy and safety of lazertinib in the treatment of EGFRmutated non-small cell lung cancer: a systematic review
    Gunawan, J. Evangeline
    ANNALS OF ONCOLOGY, 2024, 35 : S1377 - S1377
  • [49] Spectrum of EGFR gene mutations in Vietnamese patients with non-small cell lung cancer
    Hoang Anh Vu
    Phan Thi Xinh
    Hua Thi Ngoc Ha
    Ngo Thi Tuyet Hanh
    Nguyen Duc Bach
    Doan Thi Phuong Thao
    Ngo Quoc Dat
    Nguyen Sao Trung
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 (01) : 86 - 90
  • [50] Frequency and types of EGFR mutation in Moroccan patients with non-small cell lung cancer
    Sow, M. L.
    El Yacoubi, H.
    Moukafih, B.
    Balde, S.
    Akimana, G.
    Elkhoyaali, S.
    Abahssain, H.
    Mrabti, H.
    Elghissassi, I.
    Errihani, H.
    ANNALS OF ONCOLOGY, 2019, 30
12345